Navigation Links
Obio Pharmaceutical Announces Product Growth Strategy
Date:2/18/2009

n antiviral drug candidate -- TG21 that could tackle avian and human influenza virus. Thanks to the US Food and Drug Administration (FDA) and EU European Medicines Agency (EMA) previous approval of the active ingredient of TG21 as an orphan drug, its safety profile is assured. As cases of resistance to the mainstream medical intervention -- Tamiflu are on the rise, TG21 can be considered an alternative drug preparing for possible pandemic threat. TG21 works on a different mechanism to that of both Tamiflu and Relenza, which are Neuraminidase Inhibitors. TG21 does not work on the same target so the influenza virus is less likely to develop resistance to TG21.

A US Patent Attorney has prepared a patentability report for TG21, application of patents has also been filed on TG21 and pending approval. As a drug research and discovery company, Obio is in process to apply for a fast track mode to accelerate drug registration given the needs of effective treatment for lethal influenza viruses are unmet, and actively negotiating partnership with large pharmaceuticals companies to produce the drug.

Apart from the aforementioned drug candidates, the Company continues to push research of its candidates in life-style and Parkinson disease arenas. The Company believes that its research focus will achieve the Company vision to research and develop novel drugs, and bring them into the market through co-development with other prestigious pharmaceutical companies.

Dr. Bill Chan, Director and Chief Technical Officer of the Company, said, "All the drug candidates on hand should be able to capture the attention from the pharmaceutical industries. Some of them have high chance to become blockbuster drugs after analyzing the market demand. Now, Obio holds all the aces and ready to launch its products; the growth strategy in launching the blockbuster drugs together with other pharmaceutical companies will certainly accelerate
'/>"/>

SOURCE Obio Pharmaceutical Holdings Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
2. Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
3. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
4. TechniKroms Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
5. Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
6. Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM)
7. Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
8. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
9. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
10. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
11. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... first in class collagenase-based products marketed as XIAFLEX ... the U.S. and XIAPEX ® in the ... a randomized, double-blind Phase 2a study of CCH ... fibrosclerotic panniculopathy. The results showed that all three ...
(Date:8/21/2014)... A Finnish-Swedish research group at the Institute for ... Karolinska institutet, Stockholm, has developed a novel "man ... infection. This innovative diagnostic aid was described in ... August. The method is based on computer vision ... systems combined with visualization of only the diagnostically ...
(Date:8/21/2014)... 21, 2014 2014 Deep ... is a professional and in-depth research report ... provides basic Seaweed Fertilizer information, including Seaweed ... structure as well as industry overview. This ... domestic market as well as global industry ...
(Date:8/21/2014)... IA (PRWEB) August 21, 2014 His ... LIBERTY Opening , The Court of His Majesty Willem-Alexander, ... will attend the Grand Opening of POET-DSM Advanced Biofuels’ ... Wednesday, Sept. 3. , The King will take part ... opening activity, scheduled for 11 a.m.-12:20 p.m. and tour ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5A novel 'man and machine' decision support system makes malaria diagnostics more effective 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 2Internationals Seaweed Fertilizer Industry 2014 Development Trend Analysis in New Research Study at DeepResearchReports.com 3His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3
... in Nature Nanotechnology questions whether industry, government ... technologies to ensure the safe and responsible development of ... the 12 "late lessons from early warnings," published by ... emerging field of nanotechnology. EEA,s "lessons" are drawn ...
... July 21 Zenobia Therapeutics, Inc.,(Zenobia) announced today ... La Jolla, California. Zenobia was founded June 1, ... laboratory and office facilities,on July 1. The Zenobia ... biology and fragment-based lead discovery (FBLD)., Zenobia ...
... July 21 Abingdon Life Sciences,announces the formal ... located at 5963 La Place Court, Suite 107, ... Palomar Airport. Abingdon Life Sciences,Inc. is a first-in-class ... providing drug and device companies with,superior services based ...
Cached Biology Technology:Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company 2Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad, Ca. 2
(Date:8/20/2014)... a John and Rebecca Moores Professor of Biology and Biochemistry ... in the International Society for the Study of the Origin ... members two from the U.S., one from France and ... are elected every three years, and 36 have been named ... 20 countries, the ISSOL includes researchers from disciplines as varied ...
(Date:8/20/2014)... 20, 2014 /CNW/ -  Issue Serious ... quickly become life threatening for some children.    ... million Canadians have food allergies and this number may be ... children are estimated to have food allergies.  ... irritations and hives to breathing difficulties and loss of consciousness. ...
(Date:8/20/2014)... 19, 2014 -- Bay Area Lyme Foundation, which aims ... to cure, applauds new research published in an upcoming ... and Tick-borne Diseases . The findings show that ... active throughout the year, making the threat of Lyme ... California Department of Public Health (CDPH) Vector-borne Disease Section ...
Breaking Biology News(10 mins):UH professor named fellow by International Astrobiology Society 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3
... German . , The sea-ice is getting thinner ... the Arctic Ocean,Bremerhaven, September 13, 2007. Large areas of ... equating to an approximate 50 percent thinning as compared to ... latest Alfred-Wegener-Institute for Polar and Marine Research in the Helmholtz ...
... -- Peering at microscopic changes within the retina, scientists in ... New York City, have discovered a key mechanism driving eye ... article of a recent edition of Cell, the team says ... rod cells regenerate themselves. The retina uses two ...
... WASHINGTON, Sept. 12 J. Michael McConnell, Director ... Secretary of Defense,for Intelligence will provide valuable insights ... vision for implementing the United States,Intelligence Community 100 ... the Conference: The Office of the Director ...
Cached Biology News:The sea ice is getting thinner 2The sea ice is getting thinner 3The sea ice is getting thinner 4Scientists eye secrets of retinal regeneration 2
RatTRAPTM Assay is a solid-phase immunofixed enzyme activity assay for the determination of osteoclast-derived TRACP 5b activity in rat serum....
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... (TdT) is an intracellular marker normally present ... minor subpopulation of bone marrow prelymphocytes. Elevated ... of TdT cells are found to be ... Presence of TdT thus provides a useful ...
Recombinant Ovine IFN Tau. Active on sheep, cow, human and mouse cells. Activity: 5.7 x 10 7 u/mg...
Biology Products: